COMP <GO>
CHCT vs BRK-B // GROSS PROFIT MARGIN
Community Healthcare Trust Incorporated (NYSE) VS. Berkshire Hathaway Inc. (Class B) (NYSE) • 15-METRIC TALLY: CHCT 3
— BRK-B 5
■ METRIC PARITY
LAST: $13.05 (+2.35%) • MKT CAP: $373.9M
gross-margins
—
LAST: $541.96 (+0.30%) • MKT CAP: $1.20T
gross-margins
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CHCT VS. BRK-B)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CHCT | BRK-B | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin ACTIVE | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 1.20% | 11.47% | -10.27 | BRK-B | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 9.7x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 15.09% | 2.09% | +13.00 | CHCT | /fcf-yield <GO> |
| Operating Margin | — | 27.80% | — | TIE | /operating-margins <GO> |
| Net Profit Margin | 4.20% | 22.30% | -18.10 | BRK-B | /net-margins <GO> |
| Revenue Growth (YoY) | 4.70% | 3.93% | +0.77 | CHCT | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 4/9 | +2.00 | CHCT | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 3.55% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 41.8 | 67.7 | -25.90 | BRK-B | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.61 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 68.2x | 24.3x | +43.86 | BRK-B | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $373.9M | $1.20T | -$1.20T | BRK-B | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CHCT REV | BRK-B REV | CHCT GROSS % | BRK-B GROSS % | CHCT FCF | BRK-B FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $121.2M | $371.44B | — | — | $56.4M | $25.04B |
| FY 2024 | $115.8M | $371.43B | — | — | $58.9M | $11.62B |
| FY 2023 | $112.8M | $364.48B | — | — | $61.4M | $29.79B |
| FY 2022 | — | $302.02B | — | — | — | $21.89B |
| FY 2021 | — | $276.19B | — | — | — | $26.15B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CHCT // BETA —
BRK-B // BETA 0.61